Truscreen CEO Marty Dillon Tells JustStocks Video Of Plans To Be Cashflow Positive By End Of FY25

Truscreen Group Limited (NZX/ASX: TRU) CEO Marty Dillon introduces the medical device company to investors and JustStocks Video. TRU has developed and manufactures an AI-enabled device for detecting abnormalities in the cervical tissue in real-time. So far more than 200 devices have been installed and used in China, Vietnam, Mexico, Zimbabwe, Russia, and Saudi Arabia. Dillon says the company’s ambition is to be cashflow positive every month by the end of FY25.

Articles of Interest